Prevalence of serum galectin‑1 autoantibodies in seven types of cancer: A potential biomarker-Reference-Cited by-同舟云学术

Prevalence of serum galectin‑1 autoantibodies in seven types of cancer: A potential biomarker

Published:2021-07-01 Issue:3 Volume:15 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Nanami Tatsuki¹,Hoshino Isamu²,Shiratori Fumiaki¹,Yajima Satoshi¹,Oshima Yoko¹,Suzuki Takashi¹,Ito Masaaki¹,Hiwasa Takaki³,Kuwajima Akiko⁴,Shimada Hideaki¹

Affiliation:

1. Department of Surgery, School of Medicine, Toho University, Tokyo 143‑8541, Japan

2. Division of Gastroenterological Surgery, Chiba Cancer Center, Chiba 260‑8717, Japan

3. Department of Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 143‑8541, Japan

4. Medical and Biological Laboratories Co., Ltd., Nagoya, Aichi 460‑0008, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction;Cancers;2023-08-18

2. A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations;Cancers;2023-08-11

3. Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study;Scientific Reports;2023-04-03

4. Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: A prospective cross-sectional study;2023-01-09

5. High proprotein convertase subtilisin/kexin type 9 antibody level is associated with poor prognosis in patients with diabetes: A Prospective cross-sectional study;2023-01-04